If you are going to run an unvalidated compound, run one at a time so that anything that happens can actually be attributed
Semaglutide may be an excellent option for individuals who meet the following criteria: BMI Criteria: Individuals with a BMI of 27 or higher with at least one weight-related condition, or a BMI of 30 or higher
Tirzepatide is a dual GIP/GLP-1 agonist with a different molecular structure, which means its degradation characteristics are not identical
Upon comparison, patients in the GLP-1 group exhibited a lower risk of recurrence of acute pancreatitis (15.2%) as compared to the 24% in the SGLT2 inhibitor group
And in some cases, it might mean switching from tirzepatide to semaglutide or vice versa
However, the key to lasting success is adopting sustainable lifestyle changes, such as: Working with a nutrition counselor to establish healthy eating habits